|
Abstract
|
|
|---|---|
| The aim of this work was to adapt BioD Point of Care technology in order to evaluate immunologic system inhibitors through a chemical assay that is able to identify the inhibition ability of new drugs for the treatment of autoimmune disease. | |
|
International
|
Si |
|
Congress
|
Industrial Research Meeting |
|
|
970 |
|
Place
|
Madrid |
|
Reviewers
|
Si |
|
ISBN/ISSN
|
978-84-16397-58-7 |
|
|
|
|
Start Date
|
04/04/2017 |
|
End Date
|
05/04/2017 |
|
From page
|
47 |
|
To page
|
47 |
|
|
BIOCHEMICAL ASSAY DEVELOPMENT FOR OPTIMIZATION OF IMMUNOLOGICAL SYSTEM INHIBITORS. Industrial Research Meeting |